Beijing, China

Xuebing Han

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Shell USA, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xuebing Han: Innovator in Battery Temperature Estimation

Introduction

Xuebing Han is a notable inventor based in Beijing, China. He has made significant contributions to the field of battery technology, particularly in estimating temperature rise rates under pulsed heating conditions. His innovative approach has implications for improving battery performance and safety.

Latest Patents

Xuebing Han holds a patent titled "Method for estimating the temperature rise rate of a battery under pulsed heating." This patent describes a method that establishes an equivalent circuit model of the battery to obtain the effective entropy potential. It also explores the relationship between the open circuit voltage and the pulsed heating current of the battery. By developing a heat generation model based on these parameters, Han provides a comprehensive estimation method for determining the heating effect of pulsed heating in practical applications. He has 1 patent to his name.

Career Highlights

Xuebing Han is currently employed at Shell USA, Inc., where he continues to work on advancements in battery technology. His expertise in this area has positioned him as a valuable asset to his team and the broader field of energy storage solutions.

Collaborations

He collaborates with talented colleagues, including Yudi Qin and Languang Lu, who contribute to his research and development efforts.

Conclusion

Xuebing Han's innovative work in battery temperature estimation showcases his commitment to enhancing battery technology. His contributions are vital for the future of energy storage and management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…